In many of these lymphomas (up to 80% in some case series), the rearrangement of MYC together with that of BCL2 and/or BCL6 has been identified, a condition defined as “double-hit” (DH) or “triple-hit” (TH) lymphomas depending on the number of pathogenetically relevant lesions identified. The gene discussed is BCL2; the disease is lymphoma.